stdClass::__set_state(array( 'id' => '1461049', 'url' => 'SR/phase_iii_trials', 'image' => '', 'title' => 'Treća faza ispitivanja', 'tags' => array ( 0 => 'Treća faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Treća faza ispitivanja', 'source_id' => 30918, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara opšte prakse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247812, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'phase iii trials', 'Definition' => 'Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iii_trials', ))

stdClass::__set_state(array( 'id' => '1467657', 'url' => 'SR/Lotronex', 'image' => '', 'title' => 'Lotronex', 'tags' => array ( 0 => 'Lotronex', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lotronex', 'source_id' => 31150, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju sindroma iritabilnog kolona kod žena', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845763, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'Lotronex', 'Definition' => 'a prescription drug used to treat IBS in women', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lotronex', ))

stdClass::__set_state(array( 'id' => '1467661', 'url' => 'SR/Paxil', 'image' => '', 'title' => 'Paxil', 'tags' => array ( 0 => 'Paxil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Paxil', 'source_id' => 31158, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju depresije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999386894336, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'Paxil', 'Definition' => 'a prescription drug used to treat depression', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Paxil', ))

stdClass::__set_state(array( 'id' => '1461317', 'url' => 'SR/market_entry', 'image' => '', 'title' => 'ulazak na tržište', 'tags' => array ( 0 => 'ulazak na tržište', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'ulazak na tržište', 'source_id' => 54584, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj kompanije da uđe na tržište preko inovacija, javne nabavke ili ekspanzijeć', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862276, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'market entry', 'Definition' => 'An attempt by a company to enter a market through innovation, acquisition or expansion.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_entry', ))

stdClass::__set_state(array( 'id' => '1461047', 'url' => 'SR/phase_i_trials', 'image' => '', 'title' => 'Prva faza ispitivanja', 'tags' => array ( 0 => 'Prva faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Prva faza ispitivanja', 'source_id' => 30916, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Početne studije sa ciljem određivanja metabolizma i farmakološkog dejstva lekova na čoveka, neželjena dejstva vezana za povećane doze, kao i sticanja ranog uvida u efikasnost leka; može uključiti ispitanike bez zdravstvenih problema odnosno pacijente.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247810, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'phase i trials', 'Definition' => 'Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_i_trials', ))

stdClass::__set_state(array( 'id' => '1461301', 'url' => 'SR/benefits', 'image' => '', 'title' => 'benefit', 'tags' => array ( 0 => 'benefit', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'benefit', 'source_id' => 40068, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'posebne povoljnosti za zaposlene npr. plaćeno zdravstveno osiguranje', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967781765120, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'benefits', 'Definition' => 'Extra advantages offered to employees e.g. paid health insurance.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'benefits', ))

stdClass::__set_state(array( 'id' => '1461006', 'url' => 'SR/orphan_drugs', 'image' => '', 'title' => 'lekovi ,,siročići\'\'', 'tags' => array ( 0 => 'lekovi ,,siročići\'\'', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'lekovi ,,siročići\'\'', 'source_id' => 30914, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kategorija Administracije za hranu i lekove koja se odnosi na lekove koji se koriste u lečenju retkih bolesti i stanja. Slabo ima finansijske motivacije za farmaceutsku industriju u pogčedu razvoja lekova za ovakve bolesti i stanja. Status lekova ,,siročića\'\', u svakom slučaju daje proizvođaču posebnu finansijsku motivaciju za razvoj i obezbeđivanje takvih lekova.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907780, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'orphan drugs', 'Definition' => 'An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. Orphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'orphan_drugs', ))

stdClass::__set_state(array( 'id' => '1467660', 'url' => 'SR/Norplant', 'image' => '', 'title' => 'Norplant', 'tags' => array ( 0 => 'Norplant', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Norplant', 'source_id' => 31155, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'kontraceptivno sredstvo koje se trajno implantira u pacijenta', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845766, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'Norplant', 'Definition' => 'a contraceptive device that is permanently implanted in the patient', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Norplant', ))

stdClass::__set_state(array( 'id' => '1461088', 'url' => 'SR/convention_₅', 'image' => '', 'title' => 'konvencija', 'tags' => array ( 0 => 'konvencija', 1 => 'Language', 2 => 'Terminology', 3 => '', ), 'term' => 'konvencija', 'source_id' => 1080723, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Terminology', ), 'lastedit' => '20110705163519', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Sporazum, uglavnom jednosglasno postignut od strane govornika zajednice, da se povezanost mora primenjivati između lingvističkih jedinica, između ovih i dpoljnog sveta ili primeniti pri upotrebi gramatičkih pravila datij jezika.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966616797187, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'convention', 'Definition' => 'An agreement, usually reached unconsciously by speakers in a community, that relationships are to apply between linguistic items, between these and the outside world or to apply in the use of rules in the grammar of their language.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Terminology', 'Creation User' => 'nunk0410', 'Creation Date' => '2011/4/17', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'convention_₅', ))

stdClass::__set_state(array( 'id' => '1460609', 'url' => 'SR/confidentiality_regarding_trial_participants', 'image' => '', 'title' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'tags' => array ( 0 => 'poverljivost podataka učesnika u kliničkom ispitivanju', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'source_id' => 30883, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705083507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na poštovanje poverljivosti podataka učesnika u kliničkom ispitivanju uključujući njihov identitet i sve lične medicinskwe informacije. Odobrenje za korišćenje dobijenih podataka radi verifikacije samih podataka mora unapred biti dobijeno od učesnika ispitivanja kao i uverenje da poverljivost mora biti zagarantovana.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964695805952, 'nstext_full' => 'Serbian (SR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'confidentiality regarding trial participants', 'Definition' => 'Refers to maintaining the confidentiality of trial participants including their personal identity and all personal medical information. The trial participants\' consent to the use of records for data verification purposes should be obtained prior to the trial and assurance must be given that confidentiality will be maintained.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'confidentiality_regarding_trial_participants', ))